Focus on Children's Health

Human Papillomavirus Vaccine Uptake in Adolescent Boys: An Evidence Review

October 26, 20165 min
Host: David L. Bell, MD, MPH Human Papillomavirus Vaccine Uptake in Adolescent Boys: An Evidence Review Voss DS1, Wofford LG2. Worldviews Evid Based Nurs. 2016 Jul 26. doi: 10.1111/wvn.12172. [Epub ahead of print] Abstract BACKGROUND:Despite evidence-based guidelines recommending routine vaccination against human papillomavirus (HPV) for adolescent boys, ages 11-12 years, vaccine uptake among this population remains low. AIMS:To examine reasons for low HPV quadrivalent vaccine uptake and methods available to increase vaccine uptake among adolescent males, ages 11-12 years. METHODS AND RESULTS:Of 341 identified studies, 30 were included from three databases. The 30 studies were grouped into six categories: population-specific, problem-specific, educational interventions, theory-specific, political implications, and foundational guidelines and Websites. DISCUSSION:Among eight studies, low vaccine uptake was attributed to lack of parental, adolescent, and physician knowledge of HPV

Chat About Human Papillomavirus Vaccine Uptake in Adolescent Boys: An Evidence Review